Home

Oxygenta Pharmaceutical Ltd PE Ratio

Image

Oxygenta Pharmaceutical Ltd

NSE: OXYGENTAPHARMA

PE

-

Last updated on: Apr 03, 2025

Key Highlights

  • The P/E Ratio of Oxygenta Pharmaceutical Ltd is 0 as of 03 Apr 9.00 AM .
  • The P/E Ratio of Oxygenta Pharmaceutical Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 years.
  • The Latest Trading Price of Oxygenta Pharmaceutical Ltd is ₹ 80.14 as of 03 Apr 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 21.0 to 40.0 in 5 years. This represents a CAGR of 13.75%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.2. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 37.1 in 2024.

Historical P/E Ratio of Oxygenta Pharmaceutical Ltd

No data available

Company Fundamentals for Oxygenta Pharmaceutical Ltd

Image

Oxygenta Pharmaceutical Ltd

NSE: OXYGENTAPHARMA

Share Price

₹ 80.14

1.39 (1.77%)

stock direction

Last updated on: Apr 03, 2025

Market Price of Oxygenta Pharmaceutical Ltd

1M

1Y

3Y

5Y

Monitoring Oxygenta Pharmaceutical Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
03 Apr 202580.14
02 Apr 202578.75
01 Apr 202578.92
28 Mar 202579.56
27 Mar 202579.97
26 Mar 202576.76
25 Mar 202580.79
24 Mar 202579.01
21 Mar 202578.54
20 Mar 202578.61

SWOT Analysis Of Oxygenta Pharmaceutical Ltd

Strength

0

che

Weakness

2

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Oxygenta Pharmaceutical Ltd

Asset Value vs Market Value of Oxygenta Pharmaceutical Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Oxygenta Pharmaceutical Ltd296.39
Sun Pharmaceutical Industries Ltd424706
Divis Laboratories Ltd152946
Cipla Ltd120751
Torrent Pharmaceuticals Ltd109983
Mankind Pharma Ltd100168

PE Ratio of Oxygenta Pharmaceutical Ltd Explained

296.39

Market cap

0

Earnings

0.0X

PE Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Oxygenta Pharmaceutical Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Oxygenta Pharmaceutical Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Oxygenta Pharmaceutical Ltd

No data available

* All values are in %

About Oxygenta Pharmaceutical Ltd

  • Oxygenta Pharmaceutical Limited (Formerly known S S Organics Ltd) was incorporated as Private Limited Company in year 1990 and converted into a Limited Company in 1993, with the objective of carrying on the business of manufacturing all classes and kinds of Drugs including Pharmaceutical preparation, and Organic Fine Chemicals.
  • Later, the Company changed its name from S.S. Organics Ltd. to Oxygenta Pharmaceutical Limited in 2021-22. The Company is strong in manufacturing of anti ulcerative and anti bacterial drugs.
  • The Company is doing contract manufacturing work for APL and also having its own production.
  • The Company is engaged in manufacture of bulk drugs.
  • It manufactures a wide range of new generation quinolones, antiasthmatic, antiulcerant, and anti-inflammatory drugs.

Oxygenta Pharmaceutical Ltd News Hub

Oxygenta Pharmaceutical reports standalone net loss of Rs 1.36 crore in the June 2024 quarter

Net Loss of Oxygenta Pharmaceutical reported to Rs 1.36 crore in the quarter ended June 2024 as agai

Read more

16 Aug 24

Oxygenta Pharmaceutical to discuss results

Oxygenta Pharmaceutical will hold a meeting of the Board of Directors of the Company on 14 August 20

Read more

12 Aug 24

Oxygenta Pharmaceutical schedules AGM

Oxygenta Pharmaceutical announced that the 31th Annual General Meeting (AGM) of the company will be

Read more

18 Sept 24

Oxygenta Pharmaceutical announces board meeting date

Oxygenta Pharmaceutical will hold a meeting of the Board of Directors of the Company on 14 November

Read more

11 Nov 24

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Oxygenta Pharmaceutical Ltd

What is the current PE Ratio of Oxygenta Pharmaceutical Ltd?

The Current PE Ratio of Oxygenta Pharmaceutical Ltd is 0.0 as on 3 Apr 2025.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 3 Apr 2025.

What was the PE Ratio of Oxygenta Pharmaceutical Ltd last year?

The PE Ratio of Oxygenta Pharmaceutical Ltd was 0.0 last year, now the PE ratio is 0.0, showing a year-on-year growth of -%.

What does the PE Ratio of Oxygenta Pharmaceutical Ltd indicate about its stock?

The PE Ratio of Oxygenta Pharmaceutical Ltd is 0.0. This ratio indicates that investors are willing to pay 0.0 times the earnings per share for each share of Oxygenta Pharmaceutical Ltd.

What is the PE Ratio Growth of Oxygenta Pharmaceutical Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Oxygenta Pharmaceutical Ltd grew by -% whereas, the EPS ratio grew by -232.1.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions